TUESDAY, NOVEMBER 21, 2017

DNA2.0 announces biopharmaceutical partnership with St. George's

DNA2.0, a Menlo Park, California-based bioengineering solutions provider, announced a partnership on Thursday with the Infection and Immunity Research Centre at St. George's at the University of London to develop plant-based pharmaceuticals. Read More »

Menon Biosensors successfully detects plague in thousands of samples

Yersinia pestis Read More »

Mosquito-borne virus immune avoidance mechanism may lead to treatment

Mosquito Read More »

BioCryst files FDA New Drug Application for peramivir

BioCryst Pharmaceuticals, Inc., recently announced that it submitted a New Drug Application to the U.S. Food & Drug Administration for its intravenous drug peramivir. Read More »

WCCT Global completes research unit for vaccine clinical trials

WCCT Global, a contract research organization, announced the completion on Thursday of a specialized clinical research unit for vaccine clinical trials. Read More »

Understanding about key flu protein could help with universal vaccine

Improved understanding of the structure of a key influenza virus surface protein could result in a new vaccine target, according to research recently published in the Proceedings of the National Academy of Sciences. Read More »

H1N1-triggered narcolepsy caused by "molecular mimicry"

H1N1 Read More »

WHO announces first ever human case of H10N8

Influenza Read More »

New Hampshire receives highest state score for disease preparedness

The Trust for America's Health recently assessed New Hampshire's readiness to handle disease outbreaks at eight out of 10 indicators analyzed, the highest score in the country. Read More »

Influenza prevalent in New York State, new protection regulation in effect

Influenza Read More »

Texas encourages attention to flu treatment, prevention

Influenza Read More »

Global Fund and Ecobank partner to improve financial management

The Global Fund announced on December 19 that it has entered into partnership with Ecobank to provide financing, support and donor aid worth $3 million over the next three years. Read More »

Board calls on UNAIDS to support new national antiretroviral treatments

The Programme Coordinating Board on Dec. 20 ended its three-day meeting in Geneva and directed UNAIDS to support processes to revise national targets in universal access to HIV treatment. Read More »

Novation helps hospitals prepare for flu season

Novation announced on Dec. 23 that it has adjusted resources and supplier agreements to support the latest statistics from the Center for Disease Control and Prevention, which indicate cases of influenza are increasing in the United States. Read More »

Malaria treatment receives FDA Breakthrough Therapy designation

GlaxoSmithKilne and Medicines for Malaria Venture announced on Friday that tafenoquine, an investigational treatment for Plasmodium vivax malaria, received the Breakthrough Therapy designation from the U.S. Food and Drug Administration. Read More »

CHP monitors confirmed case of Middle East Respiratory Syndrome

MERS CoV Read More »

Genes regulated by testosterone may impact flu vaccine response

DNA helix Read More »

CDC reports severe pH1N1-associated illnesses

The U.S. Centers for Disease Control and Prevention recently reported a number of cases of severe respiratory illness among young and middle-aged adults infected with the 2009 pandemic flu virus. Read More »

Malaria vaccine could be improved by mixing the right protein cocktail

Sheetij Dutta, from the Walter Reed Army Institute of Research, USA, published on Thursday study results that showed how a leading vaccine for malaria could be "vastly improved." Read More »

Charity: Water raises $2 million for clean drinking water in Malawi

A charity ball held on December 23 raised almost $2 million for World Vision for the development of infrastructure to deliver clean drinking water to more than 52,000 people in the rural areas of Malawi. Read More »